BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12638533)

  • 21. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cyclooxygenase-2 inhibitors in postoperative pain management].
    Güneş Y; Işik G
    Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis associated with rofecoxib.
    Clark DW; Coulter DM
    Arch Dermatol; 2003 Sep; 139(9):1223. PubMed ID: 12975177
    [No Abstract]   [Full Text] [Related]  

  • 24. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.
    Saper J; Dahlof C; So Y; Tfelt-Hansen P; Malbecq W; Loeys T; Barraclough E; Klipfel M; Lines C; Visser H; Reines S; Yuen E;
    Headache; 2006 Feb; 46(2):264-75. PubMed ID: 16492236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extreme sinus bradycardia (30/min) with acute right heart failure under tizanidine (Sirdalud). Possible pharmacological interaction with rofecoxib (Vioxx)].
    Kick A; Bertoli R; Moschovitis G; Caduff Janosa P; Cerny A
    Med Klin (Munich); 2005 Apr; 100(4):213-6. PubMed ID: 15834531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of preoperative oral rofecoxib in pain control for third molar surgery.
    Chiu WK; Cheung LK
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jun; 99(6):e47-53. PubMed ID: 15897845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C
    Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vioxx curbs knee pain. But the competition, at higher doses, is no slouch when taken with stomach protecting medications.
    Health News; 2004 Sep; 10(9):7. PubMed ID: 15597443
    [No Abstract]   [Full Text] [Related]  

  • 32. Rofecoxib-induced pseudoporphyria.
    Markus R; Reddick ME; Rubenstein MC
    J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522
    [No Abstract]   [Full Text] [Related]  

  • 33. Treating pain after Vioxx. Should you switch to another COX-2, a traditional non-steroidal anti-inflammatory, or acetaminophen.
    Health News; 2005 Jan; 11(1):3-4. PubMed ID: 15726703
    [No Abstract]   [Full Text] [Related]  

  • 34. Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.
    Ahuja N; Singh A; Singh B
    J Pharm Pharmacol; 2003 Jul; 55(7):859-94. PubMed ID: 12906745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec.
    Moride Y; Ducruet T; Rochon S; Lavoie F
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii17-22. PubMed ID: 14585914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance induction to rofecoxib in a patient with Bartter's syndrome.
    Nucera E; Schiavino D; Pollastrini E; Manna R; Di Lillo M; Buonomo A; Roncallo C; Patriarca G
    Allergy; 2004 Jul; 59(7):788-9. PubMed ID: 15180770
    [No Abstract]   [Full Text] [Related]  

  • 37. High frequency of use of rofecoxib at greater than recommended doses: cause for concern.
    Griffin MR; Stein CM; Graham DJ; Daugherty JR; Arbogast PG; Ray WA
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):339-43. PubMed ID: 15170762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
    Biancone L; Tosti C; Geremia A; Fina D; Petruzziello C; Emerenziani S; Pallone F
    Aliment Pharmacol Ther; 2004 Apr; 19(7):755-64. PubMed ID: 15043516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-administration of rofecoxib and tramadol results in additive or sub-additive interaction during arthritic nociception in rat.
    García-Hernández L; Déciga-Campos M; Guevara-López U; López-Muñoz FJ
    Pharmacol Biochem Behav; 2007; 87(3):331-40. PubMed ID: 17570478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.